Suppr超能文献

乌吉反应合成吲哚酮-内酰胺杂化物作为选择性丁酰胆碱酯酶抑制剂

Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors.

作者信息

Brandão Pedro, López Óscar, Leitzbach Luisa, Stark Holger, Fernández-Bolaños José G, Burke Anthony J, Pineiro Marta

机构信息

University of Coimbra, CQC and Department of Chemistry, 3004-535 Coimbra, Portugal.

LAQV-REQUIMTE, Rua Romão Ramalho, 59, University of Évora, 7000 Évora, Portugal.

出版信息

ACS Med Chem Lett. 2021 Jul 23;12(11):1718-1725. doi: 10.1021/acsmedchemlett.1c00344. eCollection 2021 Nov 11.

Abstract

Molecular hybridization is a valuable approach in drug discovery. Combining it with multicomponent reactions is highly desirable, since structurally diverse libraries can be attained efficiently in an eco-friendly manner. In this work, isatin is used as the key building block for the Ugi 4-center 3-component reaction synthesis of oxindole-lactam hybrids, under catalyst-free conditions. The resulting oxindole-β-lactam and oxindole-γ-lactam hybrids were evaluated for their potential to inhibit relevant central nervous system targets, namely cholinesterases and monoamine oxidases. Druglikeness evaluation was also performed, and compounds and exhibited great potential as selective butyrylcholinesterase inhibitors, at the low micromolar range, with an interesting predictive pharmacokinetic profile. Our findings herein reported suggest oxindole-lactam hybrids as new potential agents for the treatment of Alzheimer's disease.

摘要

分子杂交是药物发现中的一种重要方法。将其与多组分反应相结合是非常可取的,因为可以以环保的方式高效地获得结构多样的文库。在这项工作中,异吲哚酮在无催化剂条件下用作通过Ugi 4中心3组分反应合成羟吲哚-内酰胺杂化物的关键构建单元。对所得的羟吲哚-β-内酰胺和羟吲哚-γ-内酰胺杂化物抑制相关中枢神经系统靶点(即胆碱酯酶和单胺氧化酶)的潜力进行了评估。还进行了类药性质评估,化合物 和 在低微摩尔范围内表现出作为选择性丁酰胆碱酯酶抑制剂的巨大潜力,具有有趣的预测药代动力学特征。我们在此报告的研究结果表明,羟吲哚-内酰胺杂化物是治疗阿尔茨海默病的新潜在药物。

相似文献

1
Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors.
ACS Med Chem Lett. 2021 Jul 23;12(11):1718-1725. doi: 10.1021/acsmedchemlett.1c00344. eCollection 2021 Nov 11.
2
The Ugi4CR as effective tool to access promising anticancer isatin-based α-acetamide carboxamide oxindole hybrids.
Beilstein J Org Chem. 2024 May 27;20:1213-1220. doi: 10.3762/bjoc.20.104. eCollection 2024.
3
One step access to oxindole-based β-lactams through Ugi four-center three-component reaction.
RSC Adv. 2018 Oct 11;8(61):34903-34910. doi: 10.1039/c8ra08165d. eCollection 2018 Oct 10.
4
The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules.
Eur J Med Chem. 2021 Feb 5;211:113102. doi: 10.1016/j.ejmech.2020.113102. Epub 2020 Dec 18.
5
Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
ChemMedChem. 2015 Mar;10(3):523-39. doi: 10.1002/cmdc.201402409. Epub 2014 Dec 23.
6
Asymmetric Ugi 3CR on isatin-derived ketimine: synthesis of chiral 3,3-disubstituted 3-aminooxindole derivatives.
Beilstein J Org Chem. 2014 Jun 18;10:1383-9. doi: 10.3762/bjoc.10.141. eCollection 2014.
7
Selective butyrylcholinesterase inhibition by isatin dimers and 3-indolyl-3-hydroxy-2-oxindole dimers.
Bioorg Med Chem Lett. 2022 Dec 1;77:129037. doi: 10.1016/j.bmcl.2022.129037. Epub 2022 Oct 25.
10
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
J Enzyme Inhib Med Chem. 2019 Dec;34(1):479-489. doi: 10.1080/14756366.2018.1545766.

引用本文的文献

1
Multicomponent reactions driving the discovery and optimization of agents targeting central nervous system pathologies.
Beilstein J Org Chem. 2024 Dec 3;20:3151-3173. doi: 10.3762/bjoc.20.261. eCollection 2024.
3
Hybrid/Chimera Drugs - Part 1 - Drug Hybrids Affecting Diseases of the Central Nervous System.
Curr Med Chem. 2025;32(23):4603-4656. doi: 10.2174/0109298673305662240702071354.
4
The Ugi4CR as effective tool to access promising anticancer isatin-based α-acetamide carboxamide oxindole hybrids.
Beilstein J Org Chem. 2024 May 27;20:1213-1220. doi: 10.3762/bjoc.20.104. eCollection 2024.
6
Ugi Four-Component Reactions Using Alternative Reactants.
Molecules. 2023 Feb 8;28(4):1642. doi: 10.3390/molecules28041642.
7
Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance.
ACS Med Chem Lett. 2022 Jun 9;13(6):871-872. doi: 10.1021/acsmedchemlett.2c00194.

本文引用的文献

1
One step access to oxindole-based β-lactams through Ugi four-center three-component reaction.
RSC Adv. 2018 Oct 11;8(61):34903-34910. doi: 10.1039/c8ra08165d. eCollection 2018 Oct 10.
2
Engaging Isatins in Multicomponent Reactions (MCRs) - Easy Access to Structural Diversity.
Chem Rec. 2021 Apr;21(4):924-1037. doi: 10.1002/tcr.202000167. Epub 2021 Feb 18.
3
The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules.
Eur J Med Chem. 2021 Feb 5;211:113102. doi: 10.1016/j.ejmech.2020.113102. Epub 2020 Dec 18.
4
The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time.
J Med Chem. 2020 Aug 13;63(15):8408-8418. doi: 10.1021/acs.jmedchem.0c00754. Epub 2020 Jul 29.
5
The chemical probe - scopes, limitations and challenges.
Expert Opin Drug Discov. 2020 Dec;15(12):1365-1367. doi: 10.1080/17460441.2020.1781086. Epub 2020 Jun 19.
6
Peptidomimetic toolbox for drug discovery.
Chem Soc Rev. 2020 Jun 7;49(11):3262-3277. doi: 10.1039/d0cs00102c. Epub 2020 Apr 7.
7
Synthesis of Biologically Active Molecules through Multicomponent Reactions.
Molecules. 2020 Jan 24;25(3):505. doi: 10.3390/molecules25030505.
8
Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review.
Curr Org Synth. 2019;16(6):855-899. doi: 10.2174/1570179416666190718153703.
9
Review on the Ugi Multicomponent Reaction Mechanism and the Use of Fluorescent Derivatives as Functional Chromophores.
ACS Omega. 2020 Jan 7;5(2):972-979. doi: 10.1021/acsomega.9b03684. eCollection 2020 Jan 21.
10
Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening.
Bioorg Med Chem Lett. 2019 Dec 15;29(24):126754. doi: 10.1016/j.bmcl.2019.126754. Epub 2019 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验